Enabling the next wave of innovative drug therapies with speciality enzymes
Pharmaceutical Technology
JUNE 29, 2022
Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications. In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market. And it’s within the family – Novozymes!”.
295 
Let's personalize your content